Clinical trial
Treatment for Adolescents With Depression Study (TADS)
NCT00006286 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00006286 |
|---|---|
| Title | Treatment for Adolescents With Depression Study (TADS) |
| Official title | Treatment for Adolescents With Depression Study (TADS) |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Depression |
| Intervention type | Behavioral, Drug |
| Interventions | Fluoxetine, Psychotherapy |
| Enrollment | 432 |
| Start date | Sep 1, 1998 |
| Completion | Mar 1, 2004 |
| First posted | Sep 15, 2000 |
| Last update posted | Apr 17, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: